We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+10.16%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$2.84B
AUM Growth
+$168M
(+6.3%)
Cap. Flow
+$56.8M
Cap. Flow
% of AUM
2%
Top 10 Holdings %
Top 10 Hldgs %
72.46%
Holding
82
New
9
Increased
14
Reduced
8
Closed
12
Top Buys
| 1 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$92.5M |
| 2 |
Protagonist Therapeutics
PTGX
|
+$61.6M |
| 3 |
Arcus Biosciences
RCUS
|
+$55.6M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$34.5M |
| 5 |
Alector
ALEC
|
+$21.1M |
Top Sells
| 1 |
Relay Therapeutics
RLAY
|
+$104M |
| 2 |
ARS Pharmaceuticals
SPRY
|
+$35.3M |
| 3 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$28.9M |
| 4 |
Nurix Therapeutics
NRIX
|
+$26M |
| 5 |
Kymera Therapeutics
KYMR
|
+$25.2M |
Sector Composition
| 1 | Healthcare | 97.98% |
| 2 | Financials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$446M
| $804M | 28.27% |
11,284,280
| – | – |
|
|
MORF
2
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $224M | 7.87% |
3,951,566
| – | – |
|
3
AnaptysBio
ANAB
$1.68B
| $204M | 7.17% |
7,521,024
| – | – |
|
|
4
Arcus Biosciences
RCUS
$3.52B
| $179M | 6.28% |
5,122,359
+1,787,112
| +54% | +$55.6M |
|
5
Xencor
XNCR
$1.11B
| $160M | 5.64% |
4,906,106
| – | – |
|
6
Nuvation Bio
NUVB
$2.03B
| $136M | 4.79% |
13,711,517
| – | – |
|
|
7
Alector
ALEC
$165M
| $114M | 4.01% |
4,994,970
+752,336
| +18% | +$21.1M |
|
|
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $82.1M | 2.89% |
464,298
| – | – |
|
|
LKFT
9
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $82M | 2.88% |
+1,558,749
| New | +$92.5M |
|
10
Shattuck Labs
STTK
$606M
| $75.6M | 2.66% |
3,709,072
+390,662
| +12% | +$8.36M |
|
11
Oric Pharmaceuticals
ORIC
$1.11B
| $72.5M | 2.55% |
3,468,944
+376,726
| +12% | +$7.64M |
|
12
Kura Oncology
KURA
$999M
| $69.8M | 2.45% |
3,724,437
| – | – |
|
|
RNAM
13
DELISTED
Avidity Biosciences
RNAM
| $68M | 2.39% |
2,759,505
+655,555
| +31% | +$14.2M |
|
|
GRTS
14
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $60.1M | 2.11% |
5,560,748
+2,139,461
| +63% | +$19.5M |
|
|
15
Relay Therapeutics
RLAY
$4.15B
| $43.7M | 1.54% |
1,385,276
-3,102,500
| -69% | -$104M |
|
|
ITOS
16
DELISTED
iTeos Therapeutics
ITOS
| $35.2M | 1.24% |
1,303,157
+267,293
| +26% | +$6.99M |
|
|
17
Nurix Therapeutics
NRIX
$2.43B
| $33.8M | 1.19% |
1,126,640
-841,310
| -43% | -$26M |
|
18
Janux Therapeutics
JANX
$975M
| $30.5M | 1.07% |
1,411,975
| – | – |
|
19
Design Therapeutics
DSGN
$847M
| $27.4M | 0.96% |
1,863,098
+603,079
| +48% | +$10M |
|
|
20
Protagonist Therapeutics
PTGX
$8.79B
| $25.6M | 0.9% |
+1,443,800
| New | +$61.6M |
|
|
DRNA
21
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $25.2M | 0.89% |
+1,249,812
| New | +$34.5M |
|
|
AKUS
22
DELISTED
Akouos Inc
AKUS
| $22.9M | 0.81% |
1,975,984
| – | – |
|
23
Solid Biosciences
SLDB
$926M
| $22M | 0.77% |
613,513
| – | – |
|
24
Edgewise Therapeutics
EWTX
$4.28B
| $21.2M | 0.75% |
1,279,175
+55,000
| +4% | +$995K |
|
25
Ovid Therapeutics
OVID
$463M
| $20.4M | 0.72% |
6,082,200
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM